These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 35294090

  • 1. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.
    Carullo V, Morrone K, Weiss M, Choi J, Gao Q, Pisharoty S, Moody K, Manwani D.
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29665. PubMed ID: 35294090
    [Abstract] [Full Text] [Related]

  • 2. Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.
    Donado C, Harris EM, Heeney MM, Solodiuk JC, Greco CD, Archer NM.
    J Pain Symptom Manage; 2023 May; 65(5):e409-e415. PubMed ID: 36641004
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
    Harris EM, Vilk E, Donado C, Williams A, Heeney MM, Solodiuk J, Greco C, Archer NM.
    Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patient-controlled Analgesia For Vaso-Occlusive Crisis: A Cohort Study.
    Averbukh Y, Porrovecchio A, Southern WN.
    Clin J Pain; 2019 Aug; 35(8):686-690. PubMed ID: 31136312
    [Abstract] [Full Text] [Related]

  • 10. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N, Floroff C, Hassig TB, Boylan A, Kanter J.
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
    Kenney MO, Becerra B, Mallikarjunan A, Shah N, Smith WR.
    Pain Med; 2022 Dec 01; 23(12):2042-2049. PubMed ID: 35708641
    [Abstract] [Full Text] [Related]

  • 16. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Russo K, Chhunchha P.
    J Pain Palliat Care Pharmacother; 2023 Jun 01; 37(2):116-122. PubMed ID: 36701332
    [Abstract] [Full Text] [Related]

  • 17. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN.
    Trials; 2023 Aug 17; 24(1):538. PubMed ID: 37587492
    [Abstract] [Full Text] [Related]

  • 18. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J, Aban I, Hilliard LM, Madison J, Bemrich-Stolz C, Howard TH, Brandow A, Waite E, Lebensburger JD.
    Pediatr Blood Cancer; 2018 Dec 17; 65(12):e27420. PubMed ID: 30151977
    [Abstract] [Full Text] [Related]

  • 19. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.
    Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Am J Hematol; 2011 Dec 17; 86(12):E70-3. PubMed ID: 21953763
    [Abstract] [Full Text] [Related]

  • 20. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA, DeSilva MS, Munube D, Nkwine R, Tumukunde J, Agaba PK, Nabukenya MT, Bulamba F, Luggya TS.
    Scand J Pain; 2018 Jan 26; 18(1):19-27. PubMed ID: 29794277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.